Northpointe Bancshares Stock (NYSE:NPB)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$17.22

52W Range

$14.28 - $19.71

50D Avg

$17.97

200D Avg

$17.53

Market Cap

$258.46M

Avg Vol (3M)

$169.61K

Beta

-0.00

Div Yield

$0.10 (0.58%)

NPB Company Profile


Northpointe Bancshares, Inc. serves as the parent company for Northpointe Bank, offering a broad spectrum of financial products and banking services throughout the United States. The organization's activities are structured into two main divisions: its Mortgage Purchase Program and Retail Banking. Customers can access digital deposit solutions such as non-interest-bearing accounts, savings accounts, money market demand accounts, and certificates of deposit. Furthermore, the company extends services to individual and business clients, provides health savings accounts, facilitates home financing, manages a dedicated mortgage purchase program, engages in residential mortgage lending, and offers custodial deposit services. Founded in 1998, Northpointe Bancshares, Inc. is based in Grand Rapids, Michigan.

Show More

Industry

Banks - Regional

Sector

Financial Services

Exchange

NYSE

ADR

-

Country

US

Employees

483

IPO Date

Feb 18, 2025

Website

NPB Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Supply Of Investigational Products$10.83M$28.10M$47.91M
Licensing and Collaboration$16.81M$-249.66M$40.12M

Fiscal year ends in Dec 25 | Currency in USD

NPB Financial Summary


Dec 25Dec 24Dec 23
Revenue$471.18M$390.45M$362.45M
Operating Income$110.39M$72.88M$44.69M
Net Income$83.41M$55.16M$33.76M
EBITDA$110.39M$76.68M$48.70M
Basic EPS$4.92$3.15$1.61
Diluted EPS$4.85$3.15$1.61

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q2 26Jul 22, 26 | 10:00 AM
Q1 26Apr 22, 26 | 10:00 AM
Q4 25Jan 21, 26 | 10:00 AM

Peer Comparison


TickerCompany
CCCCC4 Therapeutics, Inc.
BNRBurning Rock Biotech Limited
ALXOALX Oncology Holdings Inc.
ERASErasca, Inc.
ZLABZai Lab Limited
LEGNLegend Biotech Corporation
CGEMCullinan Therapeutics, Inc.